ArticleOncotarget2020

Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancer.

Chiara Nicolazzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.